Maple syrup urine disease: Further evidence that newborn screening may fail to identify variant forms
- 30 June 2010
- journal article
- case report
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 100 (2), 136-142
- https://doi.org/10.1016/j.ymgme.2009.11.010
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Maple Syrup Urine Disease: Newborn Screening Fails to Discriminate between Classic and Variant FormsClinical Chemistry, 2008
- Second-Tier Test for Quantification of Alloisoleucine and Branched-Chain Amino Acids in Dried Blood Spots to Improve Newborn Screening for Maple Syrup Urine Disease (MSUD)Clinical Chemistry, 2008
- Description of the mutations in 15 subjects with variant forms of maple syrup urine diseaseJournal of Inherited Metabolic Disease, 2007
- Variant maple syrup urine disease (MSUD)—The entire spectrumJournal of Inherited Metabolic Disease, 2006
- Newborn screening may fail to identify intermediate forms of maple syrup urine diseaseJournal of Inherited Metabolic Disease, 2006
- Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from NewbornsClinical Chemistry, 2003
- Identification of twelve novel mutations in patients with classic and variant forms of maple syrup urine diseaseHuman Mutation, 2003
- Maple Syrup Urine Disease: Identification and Carrier-Frequency Determination of a Novel Founder Mutation in the Ashkenazi Jewish PopulationAmerican Journal of Human Genetics, 2001
- Two new mutations in the human E1β subunit of branched chain α-ketoacid dehydrogenase associated with maple syrup urine diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1997
- Intellectual outcome in children with maple syrup urine diseaseThe Journal of Pediatrics, 1991